Qidi Ying

机构：Ningbo No.6 Hospital · ORCID：0000-0003-2331-3950

发表论文 22 篇 · 总被引 443 次 · h-index 9

代表论文

Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update (2017 · Renal Failure · 被引 146)
Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment (2019 · Cell Death and Disease · 被引 102)
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a) (2020 · Metabolism · 被引 71)
Unravelling lipoprotein metabolism with stable isotopes: tracing the flow (2021 · Metabolism · 被引 23)
PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin‐treated patients with very high apolipoprotein(a) concentration (2022 · Journal of Internal Medicine · 被引 17)
New Insights Into the Regulation of Lipoprotein Metabolism by PCSK9: Lessons From Stable Isotope Tracer Studies in Human Subjects (2021 · Frontiers in Physiology · 被引 17)